Filing Details
- Accession Number:
- 0001209191-20-052467
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-30 17:00:09
- Reporting Period:
- 2020-09-28
- Accepted Time:
- 2020-09-30 17:00:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1746466 | Equillium Inc. | EQ | Pharmaceutical Preparations (2834) | 821554746 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1746808 | Stephen Connelly | 2223 Avenida De La Playa, Suite 105 La Jolla CA 92037 | Chief Scientific Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-09-28 | 25,000 | $5.62 | 1,018,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 24, 2020.
- The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $5.6158. The range of sale prices on the transaction date was $5.51 to $5.82 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Billionaire Hedge Funds
